Parecoxib di sulfonamide is a process-related impurity derived from the parent NSAID prodrug Parecoxib, featuring an additional sulfonamide moiety appended to the valdecoxib core via a methylene bridge. This compound retains the ester-linked pyrrolidine ring of Parecoxib but exhibits dual sulfonamide functionalities, one conjugated to the pyrazole nitrogen and a second appended to the aromatic sulfonamide substituent. The di-sulfonamide configuration arises from a synthetic side reaction during API synthesis, introducing steric hindrance and altered solubility profiles. It serves as a critical HPLC reference standard for quantifying process impurities in Parecoxib formulations.
On RequestCCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC(=CC=C3)S(=O)(=O)NC(=O)CC)C
InChI=1S/C22H23N3O7S2/c1-4-19(26)24-33(28,29)17-11-9-15(10-12-17)21-14(3)32-23-22(21)16-7-6-8-18(13-16)34(30,31)25-20(27)5-2/h6-13H,4-5H2,1-3H3,(H,24,26)(H,25,27)
CEAGKTBVTHYQAP-UHFFFAOYSA-N